Paper - WANFANG MED ONLINE

You Position: Home > Paper

Efficacy and safety of magnesium sulfate in management of preterm labor

( views:576, downloads:236 )

Author:: No author available

Journal Title:: CHINESE JOURNAL OF PERINATAL MEDICINE

Issue:: 6

DOI:: 10.3760/cma.j.issn.1007-9408.2011.06.005

Key Word:: No keyword available

Abstract： @@ 早产作为引起新生儿疾病和死亡的主要原因,已成为产科领域内具有挑战性的问题之一.世界卫生组织将早产明确定义为在孕37周前或259 d前终止的妊娠.全球早产的发病率,特别是孕34周之前的早产发生率明显升高,病死率为75%～80%,占围产儿死亡构成比的第一位,且存活者近半数存在合并症和后遗症,其生存质量的改善远不尽人意[1].

Reference

[1]李艳,韦丽仁.小儿脑瘫的病因研究进展[J].2006,(9).
[2]吴文英,徐春琳,李海霞,等.早产儿出生前硫酸镁暴露量与脑损伤关系的研究[J].2008,(5).
[3]吴连方.预防早产，改善围产儿近远期质量[J].2008,(5).
[4]杨文庆,杨长仪,陈涵强.孕母产前应用硫酸镁与早产儿动脉导管未闭的关系[J].2010,(6).
[5]G A, Macones,H M, Sehdev,M, Berlin,etc.Evidence for magnesium sulfate as a tocolytic agent.[J].1997,52.
[6]Mittendorf R,Pryde PG.A review of the role for magnesium sulphate in preterm labour.[J].2005,112(Suppl.1).
[7]S M, Cox,M L, Sherman,K J, Leveno.Randomized investigation of magnesium sulfate for prevention of preterm birth.[J].1990,163(3).
[8]J P, Elliott.Magnesium sulfate as a tocolytic agent.[J].1983,147(3).
[9]Mittendorf R,Pryde PG.Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose.[J].2009,114(3).
[10]陈岩,潘银英,江基尧,等.硫酸镁对脑缺血再灌注损伤的保护作用[J].1996,(10).
[11]M D, Fox,J R, Allbert,J F, McCaul,etc.Neonatal morbidity between 34 and 37 weeks' gestation.[J].1900,13(5).
[12]Caughey AB,Cahill AG.Magnesium for neuroprophylaxis: fact or fiction?[J].2009,200(6).
[13]A C, Chau,H A, Gabert,J M, Miller.A prospective comparison of terbutaline and magnesium for tocolysis.[J].1992,80.
[14]C A, Crowther,J E, Hiller,L W, Doyle.Magnesium sulphate for preventing preterm birth in threatened preterm labour.[J].2002,(4).
[15]Mittendorf R,Dammann O,Lee KS.Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.[J].2006,26(1).
[16]M, Jirapinyo,P, Thuvasethakul,S, Leelaphiwat.Prospective study on premature labor with magnesium sulfate.[J].1990,16(2).
[17]V L, Katz,R M, Farmer.Controversies in tocolytic therapy.[J].1999,42.
[18]Doyle LW,Marret S,Middleton P,etc.Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.[J].2009,113(6).
[19]Doyle LW.Evaluation of neonatal intensive care for extremely low birth weight infants in Victoria over two decades: II. Efficiency.[J].2004,113(3 Pt.1).
[20]Alexander J,McIntire DD,Twickler DM.Effects of magnesium sulfate on preterm fetal cerebral blood flow using Doppler analysis: a randomized controlled trial.[J].2010,115(1).
[21]Farber NB,Olney JW,Dribben WH,etc.High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain.[J].2009,96(1).
[22]Romero R,Conde Agudelo A.Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.[J].2009,200(6).
[23]Macones GA.MgSO4 for CP prevention: too good to be true?[J].2009,200(6).
[24]Antonia Alvarez,Felipe Goni de Cerio,Francisco J. Alvarez.MgSO_4 treatment preserves the ischemia-induced reduction in S-100 protein without modification of the expression of endothelial tight junction molecules[J].2009,24(7).
[25]Moster D,Lie RT,Markestad T.Long-term medical and social consequences of preterm birth.[J].2008,359(3).
[26]Chitkara U,El Sayed-YY,Holbrook RH Jr,etc.Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labor.[J].1999,93(1).